CANCIDAS (Merck Sharp & Dohme Corp.)


Welcome to the PulseAid listing for the CANCIDAS drug offered from Merck Sharp & Dohme Corp.. This Echinocandin Antifungal [EPC],Lipopeptides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Merck Sharp & Dohme Corp.
NON-PROPRIETARY NAME: CASPOFUNGIN ACETATE
SUBSTANCE NAME: CASPOFUNGIN ACETATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Echinocandin Antifungal [EPC],Lipopeptides [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2001-01-26
END MARKETING DATE: 0000-00-00


CANCIDAS HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCANCIDAS from Merck Sharp & Dohme Corp.
LABELER NAME: Merck Sharp & Dohme Corp.
DEA SCHEDULE:
ACTIVE STRENGTH: 5(mg/mL)
START MARKETING DATE: 2001-01-26
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0006-3822_df4a2f99-0b41-4727-86ce-e50c18078089
PRODUCT NDC: 0006-3822
APPLICATION NUMBER: NDA021227

Other CASPOFUNGIN ACETATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Athenex Pharmaceutical Division, LLC.Caspofungin Acetate
Fresenius Kabi USA, LLCCaspofungin Acetate
Gland Pharma LimitedCaspofungin Acetate
Merck Sharp & Dohme Corp.CANCIDAS
Mylan Institutional LLCCaspofungin acetate